The susceptibilities to 20 antimicrobial agents of Bordetella bronchiseptica variants in C mode and degraded phases were compared with those of their parents in X mode. Increases in MICs of 4-to 32-fold were observed for ampicillin, carbenicillin, erythromycin, novobiocin, rifampin, chloramphenicol, nalidixic acid, and oxolinic acid.
Bordetella bronchiseptica, an important cause of respiratory tract disease and a frequent cause of atrophic rhinitis in swine, experiences phase variation (from phase I to rough phase) (4, 6) , and phase I cells grown at low temperatures (20 crobial susceptibility of these organisms, though differences between the susceptibilities of phase I and phase IV Bordetella pertussis strains were reported (1) . The purpose of this study was to determine the effect of antigenic modulation Strains of B. bronchiseptica examined in this study were phase I strain A19 (a primary isolate from a pig affected with atrophic rhinitis) and its substrains A19-CV200 (phase II), A19-CV300 (phase III), and A19-CV400 (rough phase). The method for induction of these variants has been described in detail (4) .
All strains were grown for 2 days at 37°C on BordetGengou agar (Difco Laboratories, Detroit, Mich.) containing approximately 2.1 x 108 CFU/ml as determined by plate count. These were then diluted 1:200 with the same broth.
For susceptibility testing, the agar dilution procedure (9) was performed with Bordet-Gengou agar (1, 2, 11), in which serial twofold dilutions of 20 antimicrobial agents (listed in Table 1 ) were incorporated. Plates were spot inoculated with an inoculum-replicating apparatus. Each prong of the replicator head delivered 5 ,ul of the bacteria, resulting in a final inoculum of approximately 5.3 x 103 CFU. The inoculated plates were incubated for 20 h at 37°C except those for the determination of MICs for C-mode cells, which were incubated at 25°C (5). All strains were tested in duplicate. The MIC was defined as the lowest concentration of an antimicrobial agent which produced complete inhibition of visible bacterial growth.
The patterns of susceptibilities are summarized in Table 1 . To ampicillin, carbenicillin, erythromycin, novobiocin, rifampin, chloramphenicol, nalidixic acid, and oxolinic acid, the cells of B. bronchiseptica A19 in C mode and degraded phases were more resistant than their parent cells in X mode, as shown by the increases in MICs of 4-to 32-fold. However, no such differences in susceptibilities were observed for any of the other drugs except sulfonamides, to which the cells in C mode and rough phase alone were more resistant. None of the variants was more susceptible than the parents to any of the drugs tested.
Increase in resistance to ampicillin, carbenicillin, erythromycin, novobiocin, rifampin, chloramphenicol, nalidixic acid, and oxolinic acid was characteristic for the cells in C mode as well as for those in degraded phases. However, no such changes in MICs were observed when Mueller-Hinton agar was used (data not shown).
With the exception of ampicillin, our results are in general agreement with those reported previously by Bannatyne and Cheung (1) , who compared the susceptibilities to nine antibiotics of B. pertussis phase IV strains with those of their phase I parents.
The biochemical nature of the antimicrobial resistance acquired was not determined, but the extensive alterations in cell surface structures including polypeptide and lipopolysaccharide compositions, which are caused by antigenic modulation or phase variation (3, 8) , may be responsible for the changes in susceptibilities to a wide variety of antimicrobial agents. In addition, in the determination of MICs for B.
bronchiseptica, we recommend the use of Bordet-Gengou agar, on which the bacterium is stable with respect to its surface components (8) .
